World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
30078
World Ranking
14028
National Ranking
533

Overview

Guido Finazzi is affiliated with the Mario Negri Institute for Pharmacological Research in Italy. Their research spans multiple fields of study, predominantly focused on Medicine and Biochemistry, Genetics and Molecular Biology. Within these broader categories, their work delves into subfields such as Biotechnology, Infectious Diseases, Genetics, Food Science, and Hematology.

The scientist has contributed extensively to specific research topics including:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Listeria monocytogenes in Food Safety
  • Microbial Inactivation Methods
  • Botulinum Toxin and Related Neurological Disorders
  • Viral gastroenteritis research and epidemiology
  • Milk Quality and Mastitis in Dairy Cows
  • Acute Myeloid Leukemia Research

Frequent publication venues for Guido Finazzi's work include:

  • European Journal of Public Health
  • American Journal of Hematology
  • Leukemia
  • International Journal of Molecular Sciences
  • Toxins

Among notable recent papers, the following publications stand out:

  • Investigation and Follow-Up of a Staphylococcal Food Poisoning Outbreak Linked to the Consumption of Traditional Hand-Crafted Alm Cheese, 2020, Pathogens
  • How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey, 2020, Leukemia
  • COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey, 2020, Leukemia
  • Evaluation of the Virulence Potential of Listeria monocytogenes through the Characterization of the Truncated Forms of Internalin A, 2023, International Journal of Molecular Sciences
  • Infant Botulism: Checklist for Timely Clinical Diagnosis and New Possible Risk Factors Originated from a Case Report and Literature Review, 2021, Toxins

Guido Finazzi's research collaborations include frequent co-authors such as:

  • Virginia Filipello
  • Marina Nadia Losio
  • Sara Arnaboldi
  • G Magagna
  • Barbara Bertasi

The body of work by Guido Finazzi reflects engagement with complex biomedical and public health challenges, bridging molecular biology and clinical hematology with food safety and infectious disease topics.

Best Publications

  • Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis

    Sergio Cortelazzo;Guido Finazzi;Marco Ruggeri;Oscar Vestri

  • Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

    Tiziano Barbui;Giovanni Barosi;Gunnar Birgegard;Francisco Cervantes

  • Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

    Roberto Marchioli;Guido Finazzi;Giorgina Specchia;Rossella Cacciola

  • Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

    Ayalew Tefferi;Juergen Thiele;Attilio Orazi;Hans Michael Kvasnicka

  • Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera

    Roberto Marchioli;Guido Finazzi;Raffaele Landolfi;Jack Kutti

  • Survival and prognosis among 1545 patients with contemporary polycythemia vera: An international study

    A Tefferi;E Rumi;G Finazzi;H Gisslinger

  • Long-term survival and blast transformation in molecularly-annotated essential thrombocythemia, polycythemia vera and myelofibrosis

    Ayalew Tefferi;Paola Guglielmelli;Dirk R. Larson;Christy Finke

  • The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto

    Paolo Rebulla;Guido Finazzi;Francesca Marangoni;Giuseppe Avvisati

  • A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).

    G. Finazzi;R. Marchioli;V. Brancaccio;P. Schinco

  • Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)

    Tiziano Barbui;Guido Finazzi;Alessandra Carobbio;Juergen Thiele

  • Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.

    Alessandro M. Vannucchi;Elisabetta Antonioli;Paola Guglielmelli;Alessandro Rambaldi

  • Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.

    Sergio Cortelazzo;Piera Viero;Guido Finazzi;Anna D'Emilio

  • Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry

    Guido Finazzi;Vincenzo Brancaccio;Marco Moia;Nicola Ciavarella

  • Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study.

    Guido Finazzi;Vanesa Caruso;Roberto Marchioli;Giovanni Capnist

  • Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera.

    Raffaele Landolfi;Leonardo Di Gennaro;Tiziano Barbui;Valerio De Stefano

  • Philadelphia chromosome-negative classical myeloproliferative neoplasms: Revised management recommendations from European LeukemiaNet

    Tiziano Barbui;Ayalew Tefferi;Alessandro M. Vannucchi;Francesco Passamonti

  • Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.

    Alessandra Carobbio;Juergen Thiele;Francesco Passamonti;Elisa Rumi

  • Myeloproliferative neoplasms and thrombosis

    Tiziano Barbui;Guido Finazzi;Anna Falanga

  • Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status

    Alessandra Carobbio;Guido Finazzi;Vittoria Guerini;Orietta Spinelli

  • Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera. Commentary

    Ayalew Tefferi;Raffaele Landolfi;Leonardo Di Gennaro;Tiziano Barbui

Frequent Co-Authors

Tiziano Barbui
Tiziano Barbui FROM-Fondazione per la Ricerca Ospedale di Bergamo
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Paola Guglielmelli
Paola Guglielmelli University of Florence
Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Francesco Passamonti
Francesco Passamonti University of Milan
Francesco Rodeghiero
Francesco Rodeghiero Yamagata University
Giovanni Barosi
Giovanni Barosi University of Pavia
Anna Falanga
Anna Falanga University of Milano-Bicocca
Mario Cazzola
Mario Cazzola University of Pavia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine offers various academic directions, especially for those drawn to the flexibility and accessibility of online learning. Online programs now cater to prospective nurses, experienced RNs, and those holding non-nursing degrees who wish to transition into healthcare.

For registered nurses seeking advancement, there are numerous cheapest rn to bsn online options. These programs are both affordable and designed for working professionals. Similarly, cheap rn to bsn programs can be an accessible pathway to enhance qualifications without incurring significant debt.

Those interested in academic leadership or research may consider phd nursing programs online. These advanced degrees can be earned remotely, providing flexibility for busy healthcare professionals.

Not everyone entering the field begins with a nursing background. If you hold a non-nursing bachelor’s degree, non nursing bachelor's to msn online programs can accelerate your journey to becoming a nurse. These innovative programs allow for a direct entry into advanced nursing roles.

Best Scientists Citing Guido Finazzi

Trending Scientists